Management of Hereditary Spastic Paraplegia: A Systematic Review of the Literature.
Ontology highlight
ABSTRACT: The term hereditary spastic paraplegia (HSP) embraces a clinically and genetically heterogeneous group of neurodegenerative diseases characterized by progressive spasticity and weakness of the lower limbs. There currently exist no specific therapies for HSP, and treatment is exclusively symptomatic, aimed at reducing muscle spasticity, and improving strength and gait. The authors set out to perform a comprehensive systematic review of the available scientific literature on the treatment of HSP, applying Cochrane Collaboration methods. The Google Scholar, PubMed and Scopus electronic databases were searched to find relevant randomized control trials (RCTs) and open-label interventional studies, prospective, and retrospective observational studies of supplements, medications, and physical th
SUBMITTER: Bellofatto M
PROVIDER: S-EPMC6349696 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
ACCESS DATA